Crossmark

Metabolic/Bariatric Surgery is Safe and Effective in People with Obesity, Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Crossref DOI link: https://doi.org/10.1007/s11695-024-07535-4

Published Online: 2024-10-17

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cohen, Ricardo V.

Azevedo, Mauricio A.

Le Roux, Carel W.

Caldeon, Lorraine PMLP

Luque, Alexandre

Fayad, Dhiego A.

Petry, Tarissa B. Z.
Funding

Funding for this research was provided by:

Johnson&Johnson Medtech,Brazil
License Information

Text and Data Mining valid from 2024-10-17

Version of Record valid from 2024-10-17
More Information

Article History

Received: 6 August 2024

Revised: 30 September 2024

Accepted: 5 October 2024

First Online: 17 October 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below